MedTrace Logo

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level

NCT05742503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-02-24

No results posted yet for this study

Summary

The aim of this study is to assess the effect of different progesterone containing contraceptive methods on safety and endogenous progesterone level

Conditions

  • Progesterone
  • Contraceptive Methods

Interventions

OTHER

Depo-Provera

Injectable progesterone

OTHER

Implanon

Etonogestrel implant

OTHER

Norgestrel

Pill containing progesterone

OTHER

Mirena

Levonorgestrel-releasing intra-uterine drug (IUD)

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Mona K Omar, MD · Assistant Professor of Obstetrics and Gynecology Department, Faculty of Medicine,Tanta University

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-30
Primary Completion
2022-03-30
Completion
2022-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05742503 on ClinicalTrials.gov